India · Delayed Price · Currency is INR Hemo Organic Statistics
Total Valuation
Hemo Organic has a market cap or net worth of INR 75.73 million. The enterprise value is 88.51 million.
| Market Cap | 75.73M |
| Enterprise Value | 88.51M |
Important Dates
The last earnings date was Saturday, October 17, 2026.
| Earnings Date | Oct 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hemo Organic has 3.47 million shares outstanding. The number of shares has increased by 2.90% in one year.
| Current Share Class | 3.47M |
| Shares Outstanding | 3.47M |
| Shares Change (YoY) | +2.90% |
| Shares Change (QoQ) | +2.63% |
| Owned by Insiders (%) | 44.49% |
| Owned by Institutions (%) | 8.08% |
| Float | 40,880 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.21 |
| PB Ratio | 2.33 |
| P/TBV Ratio | 2.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.13, with a Debt / Equity ratio of 0.40.
| Current Ratio | 22.13 |
| Quick Ratio | 16.18 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,056.50 |
Financial Efficiency
Return on equity (ROE) is -48.96% and return on invested capital (ROIC) is -8.69%.
| Return on Equity (ROE) | -48.96% |
| Return on Assets (ROA) | -5.09% |
| Return on Invested Capital (ROIC) | -8.69% |
| Return on Capital Employed (ROCE) | -9.05% |
| Weighted Average Cost of Capital (WACC) | 4.67% |
| Revenue Per Employee | 4.72M |
| Profits Per Employee | -1.46M |
| Employee Count | 5 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, Hemo Organic has paid 3.19 million in taxes.
| Income Tax | 3.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +159.81% in the last 52 weeks. The beta is 0.22, so Hemo Organic's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +159.81% |
| 50-Day Moving Average | 17.99 |
| 200-Day Moving Average | 14.24 |
| Relative Strength Index (RSI) | 55.99 |
| Average Volume (20 Days) | 21,707 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hemo Organic had revenue of INR 23.58 million and -7.30 million in losses. Loss per share was -2.05.
| Revenue | 23.58M |
| Gross Profit | 302,000 |
| Operating Income | -4.11M |
| Pretax Income | -4.12M |
| Net Income | -7.30M |
| EBITDA | -4.11M |
| EBIT | -4.11M |
| Loss Per Share | -2.05 |
Balance Sheet
The company has 128,000 in cash and 12.91 million in debt, with a net cash position of -12.78 million or -3.69 per share.
| Cash & Cash Equivalents | 128,000 |
| Total Debt | 12.91M |
| Net Cash | -12.78M |
| Net Cash Per Share | -3.69 |
| Equity (Book Value) | 32.52M |
| Book Value Per Share | 8.97 |
| Working Capital | 45.40M |
Cash Flow
| Operating Cash Flow | -31.17M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 6,000 |
| Net Borrowing | -3.50M |
| Free Cash Flow | -31.17M |
| FCF Per Share | -8.99 |
Margins
Gross margin is 1.28%, with operating and profit margins of -17.44% and -30.98%.
| Gross Margin | 1.28% |
| Operating Margin | -17.44% |
| Pretax Margin | -17.45% |
| Profit Margin | -30.98% |
| EBITDA Margin | -17.42% |
| EBIT Margin | -17.44% |
| FCF Margin | n/a |
Dividends & Yields
Hemo Organic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.90% |
| Shareholder Yield | -2.90% |
| Earnings Yield | -9.38% |
| FCF Yield | -41.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hemo Organic has an Altman Z-Score of 2.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.29 |
| Piotroski F-Score | 2 |